AstraZeneca Pays Big To Get Into RSV

 
• By Elizabeth Cairns

The UK group buys its first vaccine company, Icosavax, with an eye to its platform technology.  

Vaccine_shutterstock_1272846445_620x413.jpg

More from Deals

More from Business